Simplifying Global Compliance
The QMN Weekly Bulletin
FDA: Sun’s Caraco Can Resume Some Operations at Two Michigan Facilities
Aug. 31, 2012
Sun Pharmaceuticals’ Caraco unit may resume some of its Detroit and Wixom, Mich., operations after recent FDA inspections show it is in compliance with a 2009 consent decree. The decree relates specifically to production of Caraco’s heart failure drug carvedilol and antibiotic paramomycin.
Drug Industry Daily
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing